As we head into the home stretch of the 2025 legislative session, pressure mounts to protect patient care, hospitals and ...

Fosun Pharma continues to uphold the internationalization strategy in multiple dimensions, such as innovative R&D, licensing, manufacturing and operations as well as commercialization. In 2024, ...

We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we ...

According to a Vertex spokesperson, the drug is seeing strong initial market adoption, with growing payer coverage and ongoing clinical studies aimed at expanding its use beyond acute pain management.

The healthcare industry is experiencing a significant shift with the integration of digital innovations in cold chain ...

The industry needs to embrace innovation with technology towards novel drug development to remain relevant in the marketplace.

Drug developers can now leverage large language models to draft regulatory documents, which they hope will shorten the time ...

The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. | The ...

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

In attempt to keep R&D costs low, the vivarium business model has emerged as a crucial solution for drug developers.